StockNews.AI · 505 days
Concentra reported Q3 revenue of $489.6 million, a 3.3% increase. Net income decreased by 16.5% to $45.8 million compared to Q3 2023. Patient visits dropped 2.2%, averaging 50,916 visits per day. Concentra declared a dividend of $0.0625 per share, payable November 22, 2024. 2024 outlook projects revenue of $1.9 billion and adjusted EBITDA around $372.5 million.
Revenue growth is positive, but stagnant patient visits raise concerns.
Q3 results will impact CON performance in the upcoming quarter.
Earnings report shows growth but also some warning signs affecting market confidence.